Cyclerion Therapeutics (CYCN) Price to Book (2019 - 2025)

Cyclerion Therapeutics has reported Price to Book for 7 years, with the latest figure at 0.52 in Q4 2025.

• On a quarterly basis, Price to Book fell 44.24% year-over-year to 0.52 in Q4 2025; TTM through Dec 2025 was 0.52, a 44.24% decrease from a year earlier, with the FY2025 full-year figure at 0.36, down 61.58% from the prior year.
• Price to Book was 0.52 for Q4 2025 at Cyclerion Therapeutics, down from 0.89 in the prior quarter.
• The five-year high for Price to Book was 4.81 in Q1 2023, with the low at 0.52 in Q4 2025.
• Average Price to Book over 5 years is 1.49, with a median of 0.99 recorded in 2022.
• The sharpest annual moves came in 2021 and 2024: Price to Book jumped 218611.06% in 2021, then tumbled 83.25% in 2024.
• Over 5 years, Price to Book stood at 1.55 in 2021, then soared by 76.54% to 2.73 in 2022, then slumped by 73.13% to 0.73 in 2023, then grew by 26.15% to 0.93 in 2024, then sank by 44.24% to 0.52 in 2025.
• The last three Price to Book figures came in at 0.52 (Q4 2025), 0.89 (Q3 2025), and 1.04 (Q2 2025), per Business Quant data.